Relief at Last
Methiopropamine
Citation: Novel Zephyr. "Relief at Last: An Experience with Methiopropamine (exp92416)". Erowid.org. Aug 15, 2011. erowid.org/exp/92416
DOSE: |
insufflated | Methiopropamine | (daily) |
BODY WEIGHT: | 175 lb |
Though I plan on ordering a scale as soon as I receive my next check, I presently have none for making measurements. My first order was for 500mg of MPA, and I have approximated my doses by dividing the initial quantity into smaller, equal volumes. Especially on the first day, a mild compulsion to repeat administration has been present; and I consequently plan, as well as recommend, to consume it orally, when used on a regular basis like I have.
My first dose was approximately 25mg, around 1PM; and effects were noticeable within 20 minutes. My otherwise constant urge to sleep was thoroughly repressed, replaced by an eagerness to talk and mild, caffeine-like head-rush. Administration of a roughly equal quantity was repeated about 30 minutes after the first, which was soon followed by a slight, tolerable anxiousness. Unlike my prior encounters with amphetamines, and contrary to my expectations, MPA did not induce intrusive (or 'creative') thoughts. Though this was initially somewhat disappointing, I later discovered that MPA also failed to induce insomnia and suspect that these two effects (i.e. creative thoughts and insomnia) may be inseparable.
[I feel a need to note that my girlfriend, who very rarely uses any drugs other than caffeine and OTC painkillers, experienced intense insomnia following a day that I gave her a single oral dose of approximately 60mg, at 3PM (the lateness of the dose was obviously foolish). She reported sleeping only from 4:30AM to 6AM; though she typically sleeps from 2AM to 11AM. The side-effect of insomnia seems to depend heavily on one's physiology.]
My eagerness to talk and head-rush were no longer present about two hours after initial administration; however, my otherwise constant urge to sleep did not return. The comedown was extremely smooth; and, although I didn't feel tired, I found myself able to sleep, when I decided to do so, around 11PM that night. This was particularly unusual, because I typically experience an ironic difficulty when trying to attain sleep at night. Fewer than thirty minutes were needed, between trying to sleep and managing to do so, unlike the hour or two that I usually need (after sunset), which is especially challenging after a day of using any other chemical that effectively keeps me awake during daylight's hours.
I have continued using twice daily, typically at 10AM and 2PM, at doses between 10mg and 50mg (for daily totals of 20mg to 100mg) depending on how demanding I expect the day to be. The side-effects (such as the mild anxiousness and compulsion to repeat use) have been proportionate to dosage, but generally lessen with each passing day. Another contradiction of my expectations (based on personal experiences with amphetamines and Erowid's page on methiopropamine's effects) has been that MPA does not appear to increase my libido; however, my sexual drive has always been quite low, so this was not remarkably unusual.
Overall, I'm more impressed by the medical prowess of those who discovered and distribute this 'research chemical' than I have been with my last four years of formal therapy by 'legitimate' establishments. I can hardly imagine a means of thanking MPA's suppliers enough.
Reported Dose: '20 mg to 100 mg per day Insufflated']
Exp Year: 2011 | ExpID: 92416 |
Gender: Male | |
Age at time of experience: 22 | |
Published: Aug 15, 2011 | Views: 19,152 |
[ View PDF (to print) ] [ View LaTeX (for geeks) ] [ Swap Dark/Light ] | |
Methiopropamine (545) : Health Benefits (32), Various (28) |
COPYRIGHTS: All reports copyright Erowid.
No AI Training use allowed without written permission.
TERMS OF USE: By accessing this page, you agree not to download, analyze, distill, reuse, digest, or feed into any AI-type system the report data without first contacting Erowid Center and receiving written permission.
Experience Reports are the writings and opinions of the authors who submit them. Some of the activities described are dangerous and/or illegal and none are recommended by Erowid Center.
No AI Training use allowed without written permission.
TERMS OF USE: By accessing this page, you agree not to download, analyze, distill, reuse, digest, or feed into any AI-type system the report data without first contacting Erowid Center and receiving written permission.
Experience Reports are the writings and opinions of the authors who submit them. Some of the activities described are dangerous and/or illegal and none are recommended by Erowid Center.
Erowid Experience Vault | © 1995-2024 Erowid |